KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Receivables (2016 - 2025)

Exact Sciences (EXAS) has disclosed Change in Receivables for 11 consecutive years, with -$7.3 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables rose 51.54% to -$7.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.9 million through Dec 2025, up 5.69% year-over-year, with the annual reading at $48.9 million for FY2025, 5.69% up from the prior year.
  • Change in Receivables for Q4 2025 was -$7.3 million at Exact Sciences, up from -$46.9 million in the prior quarter.
  • The five-year high for Change in Receivables was $73.0 million in Q2 2025, with the low at -$46.9 million in Q3 2025.
  • Average Change in Receivables over 5 years is $2.6 million, with a median of $1.6 million recorded in 2022.
  • The sharpest move saw Change in Receivables surged 643.77% in 2023, then plummeted 9304.91% in 2025.
  • Over 5 years, Change in Receivables stood at -$39.2 million in 2021, then grew by 15.48% to -$33.1 million in 2022, then surged by 109.39% to $3.1 million in 2023, then crashed by 587.17% to -$15.2 million in 2024, then soared by 51.54% to -$7.3 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$7.3 million, -$46.9 million, and $73.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.